CompoSecure Reports Record Second Quarter 2024 Financial Results; Narrows 2024 Full Year Guidance to High End of Range
Q2 Net Sales up 10% to $108.6 million; Q2 Net Income up 3% to $33.6 million; Q2 Adj. EBITDA up 8% to $40.0 million
Narrows fiscal 2024 guidance; now anticipates Net Sales between $418-$428 million and Adjusted EBITDA between $150-$157 million
David Cote, former CEO of Honeywell and current executive chairman of Vertiv, to become executive chairman of CompoSecure following the acquisition of a majority interest in the Company by the David Cote Family; Expected to simplify corporate structure and unlock shareholder value
SOMERSET, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced its operating results for the second quarter ended June 30, 2024.
“I am pleased to report another record quarter of Net Sales and Adjusted EBITDA, driven by continued growth in our domestic business and strong international demand from the launch of new programs,” said Jon Wilk, President and CEO of CompoSecure. We continue to support our customer’s ability to offer highly attractive premium card programs such as the limited edition Amex White Gold Card and the first Wells Fargo and Expedia co-branded metal card, as well as driving growth with innovative products through our Echo Mirror Card and LED card.
“I am also excited to announce an expansion of our strategic partnership with Fiserv to include the marketing and reselling of Arculus Authenticate. Building on our already successful metal payment card collaboration, this partnership will enhance the ability to bring FIDO 2 secure authentication capabilities to Fiserv’s extensive customer base of financial institutions and fintechs.”
As just announced in a separate press release, the David Cote Family is investing $372 million through Resolute and Dave Cote will become the executive chairman of the board of directors of CompoSecure upon closing of the transaction. Resolute will become the majority shareholder of the Company and will focus on deploying operational and M&A best practices to drive long-term value creation for all shareholders. Importantly, the transaction will remove the dual-share structure, delivering higher retained annual cash flow and better alignment of all shareholders with the elimination of the tax distributions related to the Class B units.
Mr. Wilk continued, “I am thrilled to have David Cote serve as Executive Chairman of the Board of Directors. David’s career and track record is unparalleled, setting the standard for how organizations can simultaneously drive both short and long-term performance to realize their full potential. We believe his experience steering global public companies, such as Honeywell and Vertiv, will be invaluable to CompoSecure as we enter a new phase of growth and value creation for shareholders, employees, and customers.”
Wilk added, “Today, we have also amended our credit facility with lower rates, an upsized revolving line of credit, a longer term and more flexible covenants. This reflects the confidence our lenders have in our business and provides capacity for continued growth and to retire our exchangeable notes maturing in December 2026.”
Financial Highlights (Q2 2024 vs. Q2 2023)
- Net Sales: Net Sales increased 10% to $108.6 million compared to $98.5 million. The increase was primarily driven by continued domestic growth and improved international demand.
- Gross Profit: Gross Profit was $56.1 million or 52% of Net Sales, compared to $53.9 million or 55%. The decrease in gross margin was primarily due to product mix, as well as inflationary pressure on wages.
- Net Income/EPS: Net Income increased 3% to $33.6 million compared to $32.7 million. Net Income per share attributable to Class A common shareholders was $0.44 (Basic) and $0.32 (Diluted), compared to $0.31 (Basic) and $0.29 (Diluted) in the year-ago period.
- Adjusted Net Income/Adjusted EPS: Adjusted Net Income (a non-GAAP measure) increased 10% to $25.2 million compared to $22.9 million in the year-ago period. Adjusted EPS (a non-GAAP measure), which includes both Class A and Class B shares, was $0.31 (Basic) and $0.27 (Diluted) compared to $0.29 (Basic) and $0.25 (Diluted) in the year-ago period (see reconciliation of non-GAAP measures shown in table below).
- Adjusted EBITDA: Adjusted EBITDA (a non-GAAP measure) increased 8% to $40.0 million compared to $36.9 million, with the increase driven by net sales growth.
Liquidity and Capital Structure
Balance Sheet: At June 30, 2024, CompoSecure had $35.4 million of cash and cash equivalents and $330.9 million of total debt, which included $200.9 million of term loan and $130 million of exchangeable notes. This compares to cash and cash equivalents of $41.2 million and total debt of $340.3 million at December 31, 2023, and cash and cash equivalents of $22.6 million and total debt of $358.1 million at June 30, 2023. CompoSecure’s secured debt leverage ratio was 1.29x at June 30, 2024 compared to 1.39x at December 31, 2023 and 1.60x at June 30, 2023.
Shares Outstanding: At June 30, 2024, CompoSecure had 81.7 million shares outstanding which included 29.8 million Class A shares and 51.9 million Class B shares. This includes the effect of the May 2024 underwritten secondary offering of approximately 8.1 million shares of Class A common stock, which were converted from shares of Class B common stock (for more information on shares outstanding, both Basic and Diluted, please refer to CompoSecure’s SEC filings and the earnings presentation).
Operational Highlights
- Expanded partnership with Fiserv to market and resell Arculus Authenticate capabilities to Fiserv’s customer base
- Customer card programs launched include , , Turkish Airlines, and , a leading fintech.
- Arculus highlights:
- Remain on track for Arculus total net investment to be lower than 2023, with the expectation of turning positive for fiscal 2025
- Showcased Arculus innovation around Web3 payment capabilities using digital assets for everyday purchases at point of sale
- CompoSecure recognition:
- Won three 2024 International Card Manufactures Awards Elan Award: Best Metal Cards, Best Environmentally-Friendly Cards, and Best Secure Payment Cards
- Jon Wilk, CEO, Visionary CEO Award from the Banking Tech Awards USA
- Steve Feder, General Counsel, NJBIZ Leaders in Law Awards
- Released inaugural
2024 Financial Outlook
The Company has narrowed its previously issued fiscal 2024 guidance and now expects Net Sales to range between $418-$428 million (previously $408-428 million) and Adjusted EBITDA to range between $150-$157 million (previously $147-$157 million).
Conference Call
CompoSecure will host a conference call and live audio webcast today at 5:00 p.m. Eastern Time to discuss its financial and operational results, followed by a question-and-answer period.
Date: Wednesday, August 7, 2024
Time: 5:00 p.m. Eastern Time
If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.
A live webcast and replay of the conference call will be available on the investor relations section of CompoSecure’s website at /news-events/events.
About CompoSecure
Founded in 2000, CompoSecure (Nasdaq: CMPO) is a technology partner to market leaders, fintech’s and consumers enabling trust for millions of people around the globe. The company combines elegance, simplicity and security to deliver exceptional experiences and peace of mind in the physical and digital world. CompoSecure’s innovative payment card technology and metal cards with Arculus security and authentication capabilities deliver unique, premium branded experiences, enable people to access and use their financial and digital assets, and ensure trust at the point of a transaction. For more information, please visit and
Forward-Looking Statements
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of management. Although CompoSecure believes that its plans, intentions, and expectations reflected in or suggested by these forward-looking statements are reasonable, CompoSecure cannot assure you that it will achieve or realize these plans, intentions, or expectations. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including statements concerning CompoSecure’s possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. In some instances, these statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates” or “intends” or the negatives of these terms or variations of them or similar terminology. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements which speak only as of the date hereof. You should understand that the following important factors, among others, could affect CompoSecure’s future results and could cause those results or other outcomes to differ materially from those expressed or implied in CompoSecure’s forward-looking statements: the completion of the transactions contemplated by the proposed transactions with Resolute Partners; the ability of CompoSecure to grow and manage growth profitably; maintain relationships with customers; compete within its industry and retain its key employees; the possibility that CompoSecure may be adversely impacted by other global economic, business, competitive and/or other factors; the outcome of any legal proceedings that may be instituted against CompoSecure or others; future exchange and interest rates; and other risks and uncertainties, including those under “Risk Factors” in filings that have been made or will be made with the Securities and Exchange Commission. CompoSecure undertakes no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Use of Non-GAAP Financial Measures
This press release may include certain non-GAAP financial measures that are not prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and that may be different from non-GAAP financial measures used by other companies. CompoSecure believes EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, and Free Cash Flow are useful to investors in evaluating CompoSecure’s financial performance. CompoSecure uses these measures internally to establish forecasts, budgets and operational goals to manage and monitor its business, as well as evaluate its underlying historical performance and/or to measure incentive compensation, as we believe that these non-GAAP financial measures depict the true performance of the business by encompassing only relevant and controllable events, enabling CompoSecure to evaluate and plan more effectively for the future. Due to the forward-looking nature of the financial guidance included above, specific quantification of the charges excluded from the non-GAAP financial measures included in such financial guidance, including with respect to depreciation, amortization, interest, and taxes, that would be required to reconcile the non GAAP financial measures included in such financial guidance to GAAP measures are not available, so it is not feasible to provide accurate forecasted non-GAAP reconciliations without unreasonable effort. Consequently, no disclosure of estimated comparable GAAP measures is included, and no reconciliation of the forward-looking non-GAAP financial measures is included. In addition, CompoSecure’s debt agreements contain covenants that use a variation of these measures for purposes of determining debt covenant compliance. CompoSecure believes that investors should have access to the same set of tools that its management uses in analyzing operating results. EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, and Free Cash Flow should not be considered as measures of financial performance under U.S. GAAP, and the items excluded from EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, and Free Cash Flow are significant components in understanding and assessing CompoSecure’s financial performance. Accordingly, these key business metrics have limitations as an analytical tool. They should not be considered as an alternative to net income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flows from operating activities as a measure of CompoSecure’s liquidity and may be different from similarly titled non-GAAP measures used by other companies. Please refer to the tables below for the reconciliation of GAAP measures to these non-GAAP measures.
Corporate Contact
Anthony Piniella
Head of Global Communications, CompoSecure
(917) 208-7724
Investor Relations Contact
Sean Mansouri, CFA
Elevate IR
(720) 330-2829
| Consolidated Balance Sheet Data (in thousands) | |||||||
| June 30, 2024 | December 31, 2023 | ||||||
| Unaudited | |||||||
| ASSETS | |||||||
| CURRENT ASSETS | |||||||
| Cash and cash equivalents | $ | 35,391 | $ | 41,216 | |||
| Accounts receivable, net | 39,648 | 40,488 | |||||
| Inventories | 57,514 | 52,540 | |||||
| Prepaid expenses and other current assets | 3,928 | 5,133 | |||||
| Total current assets | 136,481 | 139,377 | |||||
| Property and equipment, net | 23,739 | 25,212 | |||||
| Right of use assets, net | 6,449 | 7,473 | |||||
| Deferred tax asset | 41,082 | 23,697 | |||||
| Derivative asset - interest rate swap | 5,182 | 5,258 | |||||
| Deposits and other assets | 422 | 24 | |||||
| Total assets | $ | 213,355 | $ | 201,041 | |||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||
| CURRENT LIABILITIES | |||||||
| Accounts payable | 9,431 | 5,193 | |||||
| Accrued expenses | 12,183 | 11,986 | |||||
| Commission payable | 5,010 | 4,429 | |||||
| Bonus payable | 5,473 | 5,616 | |||||
| Current portion of long-term debt | 13,437 | 10,313 | |||||
| Current portion of lease liabilities | 2,029 | 1,948 | |||||
| Current portion of tax receivable agreement liability | 1,425 | 1,425 | |||||
| Total current liabilities | 48,988 | 40,910 | |||||
| Long-term debt, net of deferred finance costs | 186,244 | 198,331 | |||||
| Convertible notes | 128,088 | 127,832 | |||||
| Derivative liability - convertible notes redemption make-whole provision | 544 | 425 | |||||
| Warrant liability | 10,087 | 8,294 | |||||
| Lease liabilities, operating | 5,077 | 6,220 | |||||
| Tax receivable agreement liability | 43,060 | 23,949 | |||||
| Earnout consideration liability | 383 | 853 | |||||
| Total liabilities | 422,471 | 406,814 | |||||
| Commitments and contingencies (Note 13) | |||||||
| Redeemable non-controlling interest | 516,489 | 596,587 | |||||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding | — | — | |||||
| Class A common stock, $0.0001 par value; 250,000,000 shares authorized, 29,847,338 and 19,415,123 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. | 3 | 2 | |||||
| Class B common stock, $0.0001 par value; 75,000,000 shares authorized, 51,908,422 and 59,958,422 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively. | 5 | 6 | |||||
| Additional paid-in capital | 36,258 | 39,466 | |||||
| Accumulated other comprehensive income | 4,848 | 4,991 | |||||
| Accumulated deficit | (766,719 | ) | (846,825 | ) | |||
| Total stockholders' deficit | (725,605 | ) | (802,360 | ) | |||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ | 213,355 | $ | 201,041 | |||
| Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited) | |||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Net sales | $ | 108,567 | $ | 98,527 | $ | 212,577 | $ | 193,843 | |||||||
| Operating expenses: | |||||||||||||||
| Cost of sales | 52,495 | 44,590 | 101,292 | 86,552 | |||||||||||
| Selling, general and administrative expenses | 24,279 | 23,588 | 48,357 | 47,532 | |||||||||||
| Total operating expenses | 76,774 | 68,178 | 149,649 | 134,084 | |||||||||||
| Income from operations | 31,793 | 30,349 | 62,928 | 59,759 | |||||||||||
| Total other income (expense), net | 2,062 | 3,331 | (12,836 | ) | (16,605 | ) | |||||||||
| Income before income taxes | 33,855 | 33,680 | 50,092 | 43,154 | |||||||||||
| Income tax (expense) benefit | (258 | ) | (970 | ) | 578 | 293 | |||||||||
| Net income | $ | 33,597 | $ | 32,710 | $ | 50,670 | $ | 43,447 | |||||||
| Net income attributable to redeemable non-controlling interests | $ | 22,498 | $ | 26,973 | $ | 33,629 | $ | 35,347 | |||||||
| Net income attributable to CompoSecure, Inc. | $ | 11,099 | $ | 5,737 | $ | 17,041 | $ | 8,100 | |||||||
| Net income per share attributable to Class A common stockholders - basic | $ | 0.44 | $ | 0.31 | $ | 0.74 | $ | 0.45 | |||||||
| Net income per share attributable to Class A common stockholders - diluted | $ | 0.32 | $ | 0.29 | $ | 0.49 | $ | 0.41 | |||||||
| Weighted average shares used to compute net income per share attributable to Class A common stockholders - basic (in thousands) | 25,438 | 18,537 | 23,003 | 18,087 | |||||||||||
| Weighted average shares used to compute net income per share attributable to Class A common stockholders - diluted (in thousands) | 96,641 | 35,528 | 96,438 | 35,155 | |||||||||||
| Consolidated Statements of Cash Flows (in thousands) (unaudited) | |||||||
| Six months ended June 30, | |||||||
| 2024 | 2023 | ||||||
| Cash flows from operating activities: | |||||||
| Net income | $ | 50,670 | $ | 43,447 | |||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||||
| Depreciation and amortization | 4,601 | 4,171 | |||||
| Stock-based compensation expense | 9,635 | 8,415 | |||||
| Amortization of deferred finance costs | 669 | 700 | |||||
| Change in fair value of earnout consideration liability | (470 | ) | (4,221 | ) | |||
| Revaluation of warrant liability | 1,793 | 7,968 | |||||
| Change in fair value of derivative liability | 119 | 513 | |||||
| Deferred tax (benefit) | (2,922 | ) | (1,770 | ) | |||
| Changes in assets and liabilities | |||||||
| Accounts receivable | 840 | 738 | |||||
| Inventories | (4,974 | ) | (6,515 | ) | |||
| Prepaid expenses and other assets | 1,205 | (272 | ) | ||||
| Accounts payable | 4,238 | (492 | ) | ||||
| Accrued expenses | 197 | 612 | |||||
| Other liabilities | 399 | (313 | ) | ||||
| Net cash provided by operating activities | 66,000 | 52,981 | |||||
| Cash flows from investing activities: | |||||||
| Purchase of property and equipment | (3,129 | ) | (5,697 | ) | |||
| Capitalized software expenditures | (398 | ) | — | ||||
| Net cash used in investing activities | (3,527 | ) | (5,697 | ) | |||
| Cash flows from financing activities: | |||||||
| Proceeds from employee stock purchase plan and exercises of equity awards | 221 | 389 | |||||
| Payments for taxes related to net share settlement of equity awards | (8,482 | ) | (2,483 | ) | |||
| Payment of tax receivable agreement liability | — | (2,193 | ) | ||||
| Payment of term loan | (9,375 | ) | (5,017 | ) | |||
| Tax distributions to non-controlling members | (26,167 | ) | (29,008 | ) | |||
| Special distribution to non-controlling members | (15,573 | ) | — | ||||
| Dividend to Class A shareholders | (8,922 | ) | — | ||||
| Net cash used in financing activities | (68,298 | ) | (38,312 | ) | |||
| Net (decrease) increase in cash and cash equivalents | (5,825 | ) | 8,972 | ||||
| Cash and cash equivalents, beginning of period | 41,216 | 13,642 | |||||
| Cash and cash equivalents, end of period | $ | 35,391 | $ | 22,614 | |||
| Supplementary disclosure of cash flow information: | |||||||
| Cash paid for interest expense | $ | 12,890 | $ | 13,626 | |||
| Supplemental disclosure of non-cash financing activities: | |||||||
| Derivative asset - interest rate swap | $ | (143 | ) | $ | (373 | ) | |
| Non-GAAP Adjusted EBITDA Reconciliation (in thousands) (unaudited) | |||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| (in thousands) | |||||||||||||||
| Net income | $ | 33,597 | $ | 32,710 | $ | 50,670 | $ | 43,447 | |||||||
| Add: | |||||||||||||||
| Depreciation and amortization | 2,380 | 2,131 | 4,601 | 4,171 | |||||||||||
| Interest expense, net (1) | 5,648 | 5,849 | 11,394 | 12,345 | |||||||||||
| Income tax expense (benefit) | 258 | 970 | (578 | ) | (293 | ) | |||||||||
| EBITDA | $ | 41,883 | $ | 41,660 | $ | 66,087 | $ | 59,670 | |||||||
| Stock-based compensation expense | 5,238 | 4,393 | 9,635 | 8,415 | |||||||||||
| Mark-to-market adjustments, net (2) | (7,710 | ) | (9,180 | ) | 1,442 | 4,260 | |||||||||
| Secondary offering transaction costs | 586 | — | 586 | — | |||||||||||
| Adjusted EBITDA | $ | 39,997 | $ | 36,873 | $ | 77,750 | $ | 72,345 | |||||||
(1) Includes amortization of deferred financing cost for the three and six months ended June 30, 2024 and 2023, respectively.
(2) Includes the changes in fair value of warrant liability, derivative liabilities and earnout consideration liability for the three and six months ended June 30, 2024 and 2023, respectively.
| Non-GAAP Adjusted EPS Reconciliation (in thousands) (unaudited) | |||||||||||||||
| Three months ended June 30, | Six months ended June 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| (in thousands) except per share amounts | |||||||||||||||
| Basic and Diluted: | |||||||||||||||
| Net Income | $ | 33,597 | $ | 32,710 | $ | 50,670 | $ | 43,447 | |||||||
| Add (less): provision (benefit) for income taxes | 258 | 970 | (578 | ) | (293 | ) | |||||||||
| Income before income taxes | 33,855 | 33,680 | 50,092 | 43,154 | |||||||||||
| Income tax expense (1) | (6,982 | ) | (6,190 | ) | (13,387 | ) | (11,771 | ) | |||||||
| Adjusted net income before adjustments | 26,873 | 27,490 | 36,705 | 31,383 | |||||||||||
| (Less) add: mark-to-market adjustments (2) | (7,532 | ) | (8,985 | ) | 1,323 | 3,747 | |||||||||
| Add: Secondary offering transaction costs | $ | 586 | — | 586 | — | ||||||||||
| Add: stock-based compensation | 5,238 | 4,393 | 9,635 | 8,415 | |||||||||||
| Adjusted net income | $ | 25,165 | $ | 22,898 | $ | 48,249 | $ | 43,545 | |||||||
| Common shares outstanding used in computing net income per share, basic: | |||||||||||||||
| Class A and Class B common shares (3) | 81,151 | 78,496 | 80,838 | 78,046 | |||||||||||
| Common shares outstanding used in computing net income per share, diluted: | |||||||||||||||
| Warrants (Public and Private) (4) | 8,094 | 8,094 | 8,094 | 8,094 | |||||||||||
| Equity awards | 2,490 | 3,991 | 2,600 | 4,068 | |||||||||||
| Total Shares outstanding used in computing net income per share - diluted | 91,735 | 90,581 | 91,532 | 90,208 | |||||||||||
| Adjusted net income per share - basic | $ | 0.31 | $ | 0.29 | $ | 0.60 | $ | 0.56 | |||||||
| Adjusted net income per share - diluted | $ | 0.27 | $ | 0.25 | $ | 0.53 | $ | 0.48 | |||||||
1) Calculated using the Company's blended tax rate.
2) Includes the changes in fair value of warrant liability and earnout consideration liability.
3) Assumes both Class A shares and Class B shares participate in earnings and are outstanding at the end of the period.
4) Assumes treasury stock method, valuation at assumed fair market value of $18.00.
5) The Company did not include the effect of Exchangeable Notes in its total shares outstanding used in diluted adjusted net income per share.
